<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6469474/results/search/drugs/results.xml">
  <result pre="15 years relevant efforts have been made to demonstrate that" exact="calcitonin" post="gene-related peptide (CGRP) antagonism is a valuable and druggable"/>
  <result pre="future also for patients affected by other primary headaches. Keywords" exact="calcitonin" post="gene-related peptide headache LY2951742 monoclonal antibody prophylaxis CGRP Introduction"/>
  <result pre="(eg, amitriptyline, nortriptyline), serotonin receptor antagonists (eg, pizotifene), and selective" exact="norepinephrine" post="reuptake inhibitors (SNRIs). 6 Preventive therapies may be prescribed"/>
  <result pre="to both EM and CM patients. With the exceptions of" exact="topiramate" post="and onabotulinum toxin A (the latter authorized only for"/>
  <result pre="perivascular fibers that release neuropeptides, such as substance P, and" exact="calcitonin" post="gene-related peptide (CGRP), 30 that are directly responsible for"/>
  <result pre="CGRP is a neuropeptide produced from alternative splicing of the" exact="calcitonin" post="gene. CGRP is a highly potent vasodilator and has"/>
  <result pre="a G protein-coupled receptor of the B-type constituted by the" exact="calcitonin" post="receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1),"/>
  <result pre="meningeal arteries and the middle cerebral arteries that reverses after" exact="sumatriptan" post="administration; 46 and, finally, 3) animal data suggest that"/>
  <result pre="the launch of triptans and for the first time after" exact="methysergide" post="has been withdrawn from the market, migraine patients may"/>
  <result pre="D Ghadikolaei HS Siavashi M Levetiracetam in compare to sodium" exact="valproate" post="for prophylaxis in chronic migraine headache: a randomized double-blind"/>
  <result pre="9 Assarzadegan F Tabesh H Hosseini-Zijoud SM et al. Comparing" exact="zonisamide" post="with sodium valproate in the management of migraine headaches:"/>
  <result pre="Tabesh H Hosseini-Zijoud SM et al. Comparing zonisamide with sodium" exact="valproate" post="in the management of migraine headaches: double-blind randomized clinical"/>
  <result pre="Linde M Gravdahl GB et al. A comparative study of" exact="candesartan" post="versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled,"/>
  <result pre="Gravdahl GB et al. A comparative study of candesartan versus" exact="propranolol" post="for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over"/>
  <result pre="Johari MS Beladi-Moghadam N Mazhabdar-Ghashghai H Comparing the effects of" exact="atorvastatin" post="with sodium valproate (divalproex) on frequency and intensity of"/>
  <result pre="N Mazhabdar-Ghashghai H Comparing the effects of atorvastatin with sodium" exact="valproate" post="(divalproex) on frequency and intensity of frequent migraine headaches:"/>
  <result pre="Sharafkhah M Abdolrazaghnejad A Moham-madbeigi A Faraji F Use of" exact="melatonin" post="versus valproic acid in prophylaxis of migraine patients: a"/>
  <result pre="Abdolrazaghnejad A Moham-madbeigi A Faraji F Use of melatonin versus" exact="valproic acid" post="in prophylaxis of migraine patients: a double-blind randomized clinical"/>
  <result pre="A Kane SA Tajti J Edvinsson L Differential distribution of" exact="calcitonin" post="gene-related peptide and its receptor components in the human"/>
  <result pre="Szolcsanyi J Bagdy G Sumatriptan causes parallel decrease in plasma" exact="calcitonin" post="gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin"/>
  <result pre="plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during" exact="nitroglycerin" post="induced migraine attack Cephalalgia 2005 25 3 179 183"/>
  <result pre="Lassen LH Jacobsen VB Haderslev PA et al. Involvement of" exact="calcitonin" post="gene-related peptide in migraine: regional cerebral blood flow and"/>
  <result pre="Zhang Z Wemmie JA Anderson MG Russo AF Role of" exact="calcitonin" post="gene-related peptide in light-aversive behavior: implications for migraine J"/>
  <result pre="and tolerability of MK-0974 (telcagepant), a new oral antagonist of" exact="calcitonin" post="gene-related peptide receptor, compared with zolmitriptan for acute migraine:"/>
  <result pre="new oral antagonist of calcitonin gene-related peptide receptor, compared with" exact="zolmitriptan" post="for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Lancet"/>
  <result pre="study investigators Safety and efficacy of ALD403, an antibody to" exact="calcitonin" post="gene-related peptide, for the prevention of frequent episodic migraine:"/>
  <result pre="DS Safety and efficacy of LY2951742, a monoclonal antibody to" exact="calcitonin" post="gene-related peptide, for the prevention of migraine: a phase"/>
  <result pre="Darling RJ et al. Development of a novel antibody to" exact="calcitonin" post="gene-related peptide for the treatment of osteoarthritis-related pain Osteoarthritis"/>
  <result pre="effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins," exact="calcitonin" post="gene-related peptide and other neuropeptides Neuroscience 1988 24 3"/>
  <result pre="Benschop RJ Van Hecken A et al. Translational pharmacodynamics of" exact="calcitonin" post="gene-related peptide monoclonal antibody LY2951742 in a capsaicin-induced dermal"/>
 </snippets>
</snippetsTree>
